Langerhans cell histiocytosis natural history: Difference between revisions

	Langerhans cell histiocytosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Langerhans cell histiocytosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Langerhans cell histiocytosis natural history On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Langerhans cell histiocytosis natural history All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Langerhans cell histiocytosis natural history
on Langerhans cell histiocytosis natural history
Langerhans cell histiocytosis natural history in the news
Blogs on Langerhans cell histiocytosis natural history
Directions to Hospitals Treating Langerhans cell histiocytosis
Risk calculators and risk factors for Langerhans cell histiocytosis natural history

Revision as of 15:40, 4 February 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Langerhans cell histiocytosis}}
+{{CMG}} {{AE}} {{HL}}
-Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
 ==Overview==
+==Natural History==
+==Complications==
 ==Prognosis==
-* Excellent for single foci disease.
-*With multifocal disease 60% have a chronic course, 30% achieve remission and mortality is up to 10%<ref>{{cite journal |author=Komp D, El Mahdi A, Starling K, Easley J, Vietti T, Berry D, George S |title=Quality of survival in histiocytosis X: a Southwest Oncology Group study |journal=Med. Pediatr. Oncol. |volume=8 |issue=1 |pages=35-40 |year=1980 |pmid=6969347}}</ref>.
 ==References==
 {{Reflist|2}}
@@ Line 16: / Line 12: @@
 {{WikiDoc Sources}}
-[[Category:Needs content]]
 [[Category:Disease]]
 [[Category:Autoimmune diseases]]
 [[Category:Hematology]]